Impactful trials on dyslipidaemias, fractional flow reserve, beta-blockers, and peripheral artery disease

Scritto il 30/06/2026
da Filippo Crea

No abstract

Eur Heart J. 2026 Jul 1;47(25):3227-3231. doi: 10.1093/eurheartj/ehag485.

NO ABSTRACT

PMID:42379624 | DOI:10.1093/eurheartj/ehag485